In the third episode of Season 3, we spoke with Dr. James Min, Founder and CEO of Cleerly Health, about his experience turning his clinical research into Cleerly and how he’s managed the business as the treatment of coronary artery disease evolves thanks to new research, new technology like generative AI, or new business models like value-based care reimbursement. Our discuss touches on processes to utilize to ensure product market fit, how firms should think about building healthcare AI products, and the importance of challenging dogma.